Pharma News

AbbVie, a global biopharmaceutical company, announced the start of a large Phase 3 clinical trial program to study the use of ABT-494, an investigational, once-daily, oral selective JAK1 inhibitor for the treatment of rheumatoid arthritis (RA). This program will include adult patients with inadequate responses (IR) to conventional or biologic disease-modifying antirheumatic drugs (DMARDs), as well as methotrexate-naive patients.

The U.S. Food and Drug Administration approved a new indication for the Integra Omnigraft Dermal Regeneration Matrix (Omnigraft) to treat certain diabetic foot ulcers. The matrix device, which is made of silicone, cow collagen, and shark cartilage, is placed over the ulcer and provides an environment for new skin and tissue to regenerate and heal the wound.

Sanofi and Innate Pharma announced that they have entered into a research collaboration and licensing agreement to apply Innate Pharma's new proprietary technology to the development of innovative bispecific antibody formats engaging natural killer (NK) cells to kill tumor cells through the activating receptor NKp46.

The U.S. Food and Drug Administration announced that U.S. Marshals, at the agency’s request, seized nearly 90,000 bottles of dietary supplements labeled as containing kratom. The product, manufactured for and held by Dordoniz Natural Products LLC, located in South Beloit, Illinois, is marketed under the brand name RelaKzpro and worth more than $400,000.

Advinus Therapeutics  has reached the third milestone in its research and development collaboration with Takeda Pharmaceutical Company Limited. The achievement of this milestone highlights the success of the collaboration.

Using a novel and quick drug-screening method, researchers have found that anti-HIV drugs may be effective against the deadly Ebola virus that transmits from humans to humans by infectious body fluids.

A team of US researchers including an Indian-origin scientist has identified three more genes that contribute to the most common type of glaucoma. The findings increase the total number of such genes to 15.

[adsense:336x280:8701650588]

In their quest to find new treatments that could slow, stop or reverse Parkinson's disease, a progressive neurological condition that affects movement and speech, researchers in Britain are set to investigate in humans the potential of a cholesterol-lowering drug in treating the disease.

A new therapy that helps in quick healing of colds, bronchitis and several forms of respiratory allergies was launched here on Saturday.

A new gene editing technique which was hailed as the breakthrough of 2015 by Science Magazine has been found effective in preventing retinal degeneration in a type of inherited blindness, a study says.